Amir S. Youshani

Manchester, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 15 publications

Differentiating the symptomatogenic hub from the onset zone: A network approach to insular mimicry.

Differentiating the symptomatogenic hub from the onset zone: A network approach to insular mimicry.

Journal: Epileptic disorders : international epilepsy journal with videotape

Published: February 18, 2026

Glioma-related epilepsy following low-grade glioma surgery.

Glioma-related epilepsy following low-grade glioma surgery.

Journal: Neuro-oncology advances

Published: September 02, 2024

Genomic landscape of diffuse glioma revealed by whole genome sequencing.

Genomic landscape of diffuse glioma revealed by whole genome sequencing.

Journal: Nature communications

Published: October 27, 2023

Intraparenchymal convection enhanced delivery of AAV in sheep to treat Mucopolysaccharidosis IIIC.

Intraparenchymal convection enhanced delivery of AAV in sheep to treat Mucopolysaccharidosis IIIC.

Journal: Journal of translational medicine

Published: February 24, 2023

Awake brain surgery for autistic patients: Is it possible?

Awake brain surgery for autistic patients: Is it possible?

Journal: Surgical neurology international

Published: August 10, 2022

Safety and feasibility of posterior fossa neurosurgery in the supine position - A UK series from a large centre.

Safety and feasibility of posterior fossa neurosurgery in the supine position - A UK series from a large centre.

Journal: Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia

Published: October 12, 2021

A risk assessment strategy to re-introduce elective neurosurgery patients during COVID-19.

A risk assessment strategy to re-introduce elective neurosurgery patients during COVID-19.

Journal: British journal of neurosurgery

Published: April 08, 2021

An Improved Adeno-Associated Virus Vector for Neurological Correction of the Mouse Model of Mucopolysaccharidosis IIIA.

An Improved Adeno-Associated Virus Vector for Neurological Correction of the Mouse Model of Mucopolysaccharidosis IIIA.

Journal: Human gene therapy

Published: April 26, 2019

Pre-clinical Safety and Efficacy of Lentiviral Vector-Mediated Ex Vivo Stem Cell Gene Therapy for the Treatment of Mucopolysaccharidosis IIIA.

Pre-clinical Safety and Efficacy of Lentiviral Vector-Mediated Ex Vivo Stem Cell Gene Therapy for the Treatment of Mucopolysaccharidosis IIIA.

Journal: Molecular therapy. Methods & clinical development

Published: January 14, 2019

Non-myeloablative busulfan chimeric mouse models are less pro-inflammatory than head-shielded irradiation for studying immune cell interactions in brain tumours.

Non-myeloablative busulfan chimeric mouse models are less pro-inflammatory than head-shielded irradiation for studying immune cell interactions in brain tumours.

Journal: Journal of neuroinflammation

Published: September 20, 2018

A novel adeno-associated virus capsid with enhanced neurotropism corrects a lysosomal transmembrane enzyme deficiency.

A novel adeno-associated virus capsid with enhanced neurotropism corrects a lysosomal transmembrane enzyme deficiency.

Journal: Brain : a journal of neurology

Published: November 30, 2017

A nonmyeloablative chimeric mouse model accurately defines microglia and macrophage contribution in glioma.

A nonmyeloablative chimeric mouse model accurately defines microglia and macrophage contribution in glioma.

Journal: Neuropathology and applied neurobiology

Published: November 19, 2017

Showing 1-12 of 15

Last Updated: 09/26/2026